Jacopo Leonardi

Chief Executive Officer

2024

Advisor

2020

Agent Capital, a majority woman-owned international life sciences investment firm, support disruptive healthcare companies focused on novel, differentiated therapeutics and treatments that address unmet patient needs. Agent Capital aligns with scientists, entrepreneurs, and other investors to develop the next generation of healthcare innovations, leverages our industry expertise, and successful track record to source premier deals, accelerate value, and drive successful outcomes.

Chief Executive Officer

2022 - 2023

Pheast is a preclinical stage immuno-oncology company focused on targeting cancer immune evasion pathways to activate the innate immune system in the fight against cancer. Founded in 2020 as a spinout from Stanford University and led by scientific experts in innate immunity and cancer immunotherapy, Pheast is aiming to develop novel therapies for some of the most difficult-to-treat and aggressive cancers.

President, Global Commercial Operations

2022 - 2022

Leading US and International Commercial Organizations, Commercial Development, and Global Medical Affairs for Horizon Therapeutics

Chairman and CEO

2016 - 2020

Executive Vice President & President, Immunology

2015 - 2016

General Manager, US Hemophilia

2014 - 2015

Vice President, Sales & Marketing Baxter BioTherapeutics USA

2011 - 2012

Brand Leader

2007 - 2009

Director of Marketing

2005 - 2007